Voss Jameson D, Burnett Daniel G, Olsen Cara H, Haverkos Harry W, Atkinson Richard L
Epidemiology Consult Service (J.D.V.), United States Air Force School of Aerospace Medicine, Wright Patterson Air Force Base, Ohio 45433; Department of Preventive Medicine and Biometrics (J.D.V., D.G.B., C.H.O., H.W.H.), Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814; Obetech Obesity Research Center (R.L.A.), Richmond, Virginia 23219; and Virginia Commonwealth University (R.L.A.), Richmond, Virginia 23298.
J Clin Endocrinol Metab. 2014 Sep;99(9):E1708-12. doi: 10.1210/jc.2014-1863. Epub 2014 Jun 27.
Obesity is a public health priority, which also threatens national security. Adenovirus 36 (Adv36) increases adiposity in animals and Adv36 antibody status is associated with human obesity, but it is unknown whether infection predicts the development of human adiposity.
The objective of the study was to assess infection status and subsequent weight gain.
The study had a retrospective cohort design.
The study was conducted at Air Force fitness testing and clinical encounters.
PARTICIPANTS included Air Force male enlistees, aged 18-22 years, with a baseline body mass index (BMI) of 20-30 kg/m(2) followed up from enlistment (beginning in 1995) until 2012 or separation from the Air Force.
EXPOSURE included Adv36 infection status at the time of entry.
Follow-up BMI, the primary outcome, and diagnosis of overweight/obesity by the International Classification of Diseases, ninth revision V85.25+ and 278.0* series (secondary outcome) were recorded.
The last recorded follow-up BMI was similar among infected and uninfected, 26.4 and 27.2 kg/m(2), respectively (P > .05). However, infected individuals had a higher hazard of a medical provider's diagnosis of overweight/obese over time (hazard ratio 1.8, 95% confidence interval 1.0-3.1, P = .04), adjusted for baseline BMI. Additionally, infected individuals who were lean at baseline (BMI of 22.5 kg/m(2)) had a 3.9 times greater hazard of developing an overweight/obese clinical diagnosis (95% confidence interval 1.5-9.7, P = .004) compared with uninfected lean individuals after adjusting for interaction (P = .03) between infection and baseline BMI.
The presence of Adv36 antibodies was not associated with higher BMI at baseline or follow-up within this military population. However, being infected was associated with developing a clinical diagnosis of overweight/obesity, especially among those lean at baseline.
肥胖是公共卫生的重点问题,同时也对国家安全构成威胁。腺病毒36型(Adv36)可增加动物的肥胖程度,且Adv36抗体状态与人类肥胖相关,但尚不清楚感染是否能预测人类肥胖的发展。
本研究的目的是评估感染状况及随后的体重增加情况。
本研究采用回顾性队列设计。
本研究在空军体能测试和临床诊疗中进行。
参与者包括18 - 22岁的空军男性新兵,基线体重指数(BMI)为20 - 30kg/m²,从入伍(始于1995年)开始随访至2012年或从空军退役。
暴露因素包括入伍时的Adv36感染状况。
记录随访时的BMI(主要结局)以及根据国际疾病分类第九版V85.25+和278.0*系列诊断的超重/肥胖情况(次要结局)。
在最后一次记录的随访中,感染组和未感染组的BMI相似,分别为26.4和27.2kg/m²(P > 0.05)。然而,在调整基线BMI后,随着时间推移,感染个体被医疗人员诊断为超重/肥胖的风险更高(风险比1.8,95%置信区间1.0 - 3.1,P = 0.04)。此外,在调整感染与基线BMI之间的交互作用(P = 0.03)后,基线时体重正常(BMI为22.5kg/m²)的感染个体发生超重/肥胖临床诊断的风险比未感染的体重正常个体高3.9倍(95%置信区间1.5 - 9.7,P = 0.004)。
在该军事人群中,Adv36抗体的存在与基线或随访时较高的BMI无关。然而,感染与超重/肥胖的临床诊断相关,尤其是在基线时体重正常的人群中。